Greater Philadelphia

BioBuzz Regional Round Up| Greater Philadelphia | March 14, 2025

BioBuzz Regional Round Up| Greater Philadelphia | March...

BioBuzz Media Mar 14, 2025

Third Arc Bio Announces First Patient Dosed in Phase 1 Clinical Trial of Lead T Cell Engager ARC101 to Treat CLDN6 Positive Cancers

Third Arc Bio Announces First Patient Dosed in Phase 1 ...

BioBuzz Media Mar 13, 2025

-- ARC101 is the company's first bispecific antibody targeting Claudin 6 (CLDN6)...

Children’s Hospital of Philadelphia Receives Largest Single Gift in its History to Create Roberts Children’s Health

Children’s Hospital of Philadelphia Receives Largest Si...

BioBuzz Media Mar 13, 2025

BioBuzz Regional Recap | Greater Philadelphia | March 10, 2025

BioBuzz Regional Recap | Greater Philadelphia | March 1...

BioBuzz Media Mar 7, 2025

BioBuzz Philadelphia 2025 Workforce Champion of the Year Award: Honoring Finalists Driving Innovation, Diversity, and Leadership in Life Sciences

BioBuzz Philadelphia 2025 Workforce Champion of the Yea...

BioBuzz Media Mar 4, 2025

BioBuzz Regional | Greater Philadelphia | February 28, 2025

BioBuzz Regional | Greater Philadelphia | February 28...

BioBuzz Media Mar 3, 2025

Avobis Bio Receives FDA Fast Track Designation for AVB-114 Implantable Cell Therapy for Crohn's Perianal Fistulas

Avobis Bio Receives FDA Fast Track Designation for AVB-...

BioBuzz Media Feb 28, 2025

Innovative Research to Advance Oligonucleotide Therapeutics now published in the Journal of Nucleic Acid Therapeutics

Innovative Research to Advance Oligonucleotide Therapeu...

BioBuzz Media Feb 26, 2025

Synnovation Therapeutics Announces Second Program to Enter the Clinic: First Patient Dosed in Phase I Trial with SNV4818, a Potential Best-In-Class Pan-Mutant-Selective PI3Kα Inhibitor for the Treatment of Solid Tumors

Synnovation Therapeutics Announces Second Program to En...

BioBuzz Media Feb 24, 2025

BioBuzz Regional Recap| Greater Philadelphia | February 21, 2025

BioBuzz Regional Recap| Greater Philadelphia | February...

BioBuzz Media Feb 21, 2025

John Swartley: A Catalyst for Life Sciences Innovation in Philadelphia – A BioBuzz Leader of the Year Finalist

John Swartley: A Catalyst for Life Sciences Innovation ...

BioBuzz Media Feb 19, 2025

Meet Your 2024 BioBuzz Leader of the Year Award Finalists from Greater Philadelphia

Meet Your 2024 BioBuzz Leader of the Year Award Finalis...

BioBuzz Media Feb 18, 2025

Philadelphia’s life sciences ecosystem is being built by visionary leaders who t...

UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

UPDATE - Cabaletta Bio Announces Updated Clinical Data ...

BioBuzz Media Feb 18, 2025

BioBuzz | Greater Philadelphia | February 14, 2025

BioBuzz | Greater Philadelphia | February 14, 2025

BioBuzz Media Feb 17, 2025

Is Philadelphia a Leading Advanced Therapies Hub? Experts Weigh in.

Is Philadelphia a Leading Advanced Therapies Hub? Exper...

BioBuzz Media Feb 13, 2025

Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Ocugen, Inc. Announces Dosing Completion in the Phase 2...

BioBuzz Media Feb 12, 2025

1
2
3